Walleye Capital
RPRX icon

Walleye Capital’s Royalty Pharma RPRX Stock Holding History

Walleye Capital’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,365
Closed -$354K – 5021
2025
Q1 		$354K Sell
11,365
-13,759
-55% -$436K ﹤0.01% 2830
2024
Q4 		$641K Buy
+25,124
New +$666K 0.01% 2778
2024
Q3 		– Sell
-37,635
Closed -$992K – 5815
2024
Q2 		$992K Buy
+37,635
New +$1.04M 0.01% 2858
2023
Q4 		– Sell
-55,104
Closed -$1.5M – 5764
2023
Q3 		$1.5M Buy
55,104
+30,677
+126% +$911K 0.02% 1951
2023
Q2 		$751K Buy
24,427
+2,167
+10% +$73.4K 0.01% 2097
2023
Q1 		$802K Buy
+22,260
New +$825K 0.02% 1323

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return